Abstract:AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA 1971 DNA double strand breaks (DSBs) induced by camptothecins have been shown to activate homologous recombination repair and to arrest cell cycle. There has long been a notion that cell cycle arrest would give time to cells to repair their damaged DNA ( Jakson SP, Carcinogenesis. 2002, 23: 687-96; Zhou BB, et al, Nat Rev Cancer. 2004, 4: 216-25;Pommier Y, et al. Prog Nucleic Acid Res Mol Biol. 2006, 81: 179-229 ). However, this notion simply presumes that cell cycle arrest would serve DNA repair but disregards that DNA repair efficiency could inversely affect cell cycle progression. In this study, we observed that DSBs kinetically decreased following 1-h treatment of HCT116 cells with camptothecin and its novel derivative chimmitecan ( Huang M, et al. Clin Cancer Res 2006, in press ) as revealed by the progressive dispersal of γ-H2AX foci and reduction of “comet” tails. Meanwhile, a reversible cell cycle arrest also took place marked by most cells recovering from transient S/G2 arrest and successive G2/M arrest. Moreover, the DSBs elimination was achieved prior to cell cycle normalization. In this process, the essential recombination repair protein RAD51 was detected to form DNA repair foci and abrogation of RAD51 with specific small interfering RNAs (siRNA) left the DSBs unrepaired persistently. Unexpectedly, disruption of RAD51 made the cells continuing to stay in G2/M phase, indicating that effective repair of DNA lesions is required for the reversal of cell cycle arrest. On the other hand, both the checkpoint kinases Chk1 and Chk2 were activated by phosphorylation in response to DSBs elicited by camptothecin and chimmitecan. Using Chk1 and Chk2 siRNAs revealed that the down-regulation of Chk1 but not of Chk2 abrogated RAD51 foci formation and DSBs removal whereas Chk2 was indispensable for G2/M arrest. Notably, Chk1 knockdown also slightly reduced the cells in G2/M arrest. Chk2 siRNA resulted in obvious apoptosis in the cells treated with camptothecins following the abrogation of G2/M arrest, suggesting that DSBs could not be repaired effectively. Therefore, we propose that the remaining amount of DSBs, which exactly corresponds to the DNA repair progression if DSBs has been discontinued, could be the most critical factor in determining the proportion of cells recovering from the cell cycle arrest while cell cycle arrest could also be critical for proper DNA repair. Taken together, our results uncover the interdependence of homologous recombination repair and cell cycle arrest in response to DSBs induced by camptothecins.

Inhibition of CHK1 Kinase by Gö6976 Converts 8-Chloro-adenosine-induced G2/M Arrest into S Arrest in Human Myelocytic Leukemia K562 Cells

Different Mechanisms of 8-Chloro-adenosine-induced G_2/M Arrest in SH-SY5Y and SK-N-SH Cells

Checkpoint Kinase Inhibitor AZD7762 Enhance Cisplatin-Induced Apoptosis in Osteosarcoma Cells.

8-Chloroadenosine Induced HL-60 Cell Growth Inhibition, Differentiation, and G0/G1 Arrest Involves Attenuated Cyclin D1 and Telomerase and Up-Regulated P21waf1/cip1

Inhibition of topoisomerase II by 8-chloro-adenosine triphosphate induces DNA double-stranded breaks in 8-chloro-adenosine-exposed human myelocytic leukemia K562 cells

Exposure of Human Lung Cancer Cells to 8-Chloro-adenosine Induces G2/M Arrest and Mitotic Catastrophe

E2f1 Enhances 8-Chloro-adenosine-induced G2/M Arrest and Apoptosis in A549 and H1299 Lung Cancer Cells

Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer.

Chaetominine induces cell cycle arrest in human leukemia K562 and colon cancer SW1116 cells

Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents

A Novel Methoxybenzyl 5-Nitroacridone Derivative Effectively Triggers G1 Cell Cycle Arrest in Chronic Myelogenous Leukemia K562 Cells by Inhibiting CDK4/6-Mediated Phosphorylation of Rb

Design, Synthesis and Biological Evaluation of Thienopyridinones As Chk1 Inhibitors

Synthesis and Biological Evaluation of 2,6-Disubstituted-9h-purine, 2,4-Disubstitued-thieno[3,2-d]pyrimidine and -7H-pyrrolo[2,3-d]pyrimidine Analogues As Novel CHK1 Inhibitors.

Discovery of (R)-5-((5-(1-methyl-1h-pyrazol-4-yl)-4-(methylamino)pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a Novel CHK1 Inhibitor for Hematologic Malignancies.

E2f1-Mediated Dna Damage is Implicated in 8-Cl-adenosine-induced Chromosome Missegregation and Apoptosis in Human Lung Cancer H1299 Cells

Design, Synthesis, and Biological Evaluation of 2‐Aminothiazole Derivatives as Novel Checkpoint Kinase 1 (CHK1) Inhibitors

Small Molecule 2,3-DCPE Induces S Phase Arrest by Activating the ATM/ATR-Chk1-Cdc25A Signaling Pathway in DLD-1 Colon Cancer Cells

Novel Amidine Derivative K1586 Sensitizes Colorectal Cancer Cells to Ionizing Radiation by Inducing Chk1 Instability

Interdependence of Homologous Recombination Repair and Cell Cycle Arrest in Response to DNA Double Strand Breaks Induced by Camptothecins

The Radioresistance to Killing of A1–5 Cells Derives from Activation of the Chk1 Pathway

8-Chloro-adenosine Inhibits Growth at Least Partly by Interfering with Actin Polymerization in Cultured Human Lung Cancer Cells